TrialJapanese journal of clinical oncology2026

A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

Kota Kawabata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.